| # | Drug | Count |
|---|---|---|
| 0 | ROMIPLOSTIM | 962 |
| 1 | RUXOLITINIB | 798 |
| 2 | ELTROMBOPAG OLAMINE | 486 |
| 3 | PREDNISONE | 306 |
| 4 | ECULIZUMAB | 281 |
| 5 | ASPIRIN | 262 |
| 6 | ELTROMBOPAG | 258 |
| 7 | ASPIRIN 325 MG | 252 |
| 8 | ASPIRIN 81 MG | 252 |
| 9 | LENALIDOMIDE | 248 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ROMIPLOSTIM | 962 | 0.0634 |
| 1 | AVATROMBOPAG MALEATE | 117 | 0.0494 |
| 2 | RILZABRUTINIB | 20 | 0.0355 |
| 3 | CAPLACIZUMAB | 47 | 0.0263 |
| 4 | FERRIC SULFATE | 2 | 0.0250 |
| 5 | ELTROMBOPAG OLAMINE | 486 | 0.0209 |
| 6 | PACRITINIB | 51 | 0.0166 |
| 7 | CEDAZURIDINE AND DECITABINE | 12 | 0.0123 |
| 8 | RUXOLITINIB | 798 | 0.0109 |
| 9 | DANAZOL | 26 | 0.0092 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 1315 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 962 |
| 2 | Janus Kinase Inhibitor [EPC] | 818 |
| 3 | Corticosteroid [EPC] | 702 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 451 |
| 5 | Complement Inhibitor [EPC] | 288 |
| 6 | Thalidomide Analog [EPC] | 288 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 275 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 269 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 249 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 962 | 0.0634 |
| 1 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 2 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 3 | Provitamin D2 Compound [EPC] | 212 | 0.0071 |
| 4 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 12 | 0.0055 |
| 5 | Interferon alfa-2b [EPC] | 10 | 0.0054 |
| 6 | Complement Inhibitor [EPC] | 288 | 0.0051 |
| 7 | Janus Kinase Inhibitor [EPC] | 818 | 0.0051 |
| 8 | CD3-directed Antibody [EPC] | 3 | 0.0042 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 75 | 0.0039 |